These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Staphylococcus aureus in cystic fibrosis: pivotal role or bit part actor? Hurley MN; Smyth AR Curr Opin Pulm Med; 2018 Nov; 24(6):586-591. PubMed ID: 30113336 [TBL] [Abstract][Full Text] [Related]
67. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa. Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB mBio; 2020 Jun; 11(3):. PubMed ID: 32576671 [No Abstract] [Full Text] [Related]
68. Multi-Omics Study of Keystone Species in a Cystic Fibrosis Microbiome. Silveira CB; Cobián-Güemes AG; Uranga C; Baker JL; Edlund A; Rohwer F; Conrad D Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769481 [TBL] [Abstract][Full Text] [Related]
69. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Lamont IL; Konings AF; Reid DW Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260 [TBL] [Abstract][Full Text] [Related]
70. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thomas SR; Ray A; Hodson ME; Pitt TL Thorax; 2000 Sep; 55(9):795-7. PubMed ID: 10950901 [TBL] [Abstract][Full Text] [Related]
71. Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease. Lopez LR; Ahn JH; Alves T; Arthur JC Front Cell Infect Microbiol; 2022; 12():934619. PubMed ID: 35959366 [TBL] [Abstract][Full Text] [Related]
72. Dpr-mediated H Rogers RR; Kesthely CA; Jean-Pierre F; El Hafi B; O'Toole GA J Bacteriol; 2024 Jul; 206(7):e0017624. PubMed ID: 38940597 [TBL] [Abstract][Full Text] [Related]
74. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period. de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R mBio; 2017 Sep; 8(5):. PubMed ID: 28951476 [TBL] [Abstract][Full Text] [Related]
75. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. Chotirmall SH; Smith SG; Gunaratnam C; Cosgrove S; Dimitrov BD; O'Neill SJ; Harvey BJ; Greene CM; McElvaney NG N Engl J Med; 2012 May; 366(21):1978-86. PubMed ID: 22607135 [TBL] [Abstract][Full Text] [Related]
76. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Yu H; Nasr SZ; Deretic V Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612 [TBL] [Abstract][Full Text] [Related]
77. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases. Cohen LJ; Cho JH; Gevers D; Chu H Gastroenterology; 2019 Jun; 156(8):2174-2189. PubMed ID: 30880022 [TBL] [Abstract][Full Text] [Related]
78. IMOVNN: incomplete multi-omics data integration variational neural networks for gut microbiome disease prediction and biomarker identification. Hu M; Zhu J; Peng G; Lu W; Wang H; Xie Z Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37930027 [TBL] [Abstract][Full Text] [Related]